Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07220070 · ClinicalTrials.gov registry record · NA
Communication Compass
A NA study, sponsored by NYU Langone Health.
- Not yet
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT07220070: Clinical Trial NA study, sponsored by NYU Langone Health.
NCT07220070 is a NA study that has not yet begun recruiting, run by NYU Langone Health. The registered enrollment target is 120 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07220070, a NA study, has not yet begun recruiting, sponsored by NYU Langone Health.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
The primary purpose of this study is to develop, implement, and validate algorithm-based feedback reports (Communication Compass) that provides personalized, near-real-time feedback on internal medicine residents' patient education and counseling (PEC) communication skills. This research aims to address critical gaps in current communication skills training by leveraging technology to enhance the frequency and specificity of communication skills feedback while maintaining ethical standards and established educational effectiveness.
Primary Outcome
Percentage of residents rated "well done" on PEC items across all PGY2 Objective Structured Clinical Examination (OSCE) cases.
Interventions
- OTHER Algorithm-Based Feedback Reports
- OTHER Standard Curriculum
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-10-27 |
| Est. Completion | 2027-06-15 |
| Phase | NA |
What is known before NCT07220070 opens enrollment
NCT07220070 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Algorithm-Based Feedback Reports is the first listed.
NCT07220070 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07220070 about?
NCT07220070 is a clinical study titled "Communication Compass". The primary purpose of this study is to develop, implement, and validate algorithm-based feedback reports (Communication Compass) that provides personalized, near-real-time feedback on internal medicine residents' patient education and counseling (PEC) communication skills. This research aims to add...
What is the current status of trial NCT07220070?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-10-27. Estimated completion is 2027-06-15.
What interventions are being tested in trial NCT07220070?
The interventions under investigation include: Algorithm-Based Feedback Reports (OTHER), Standard Curriculum (OTHER).
Who is sponsoring clinical trial NCT07220070?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07220070's enrollment target sits among peer trials
120 762nd of 2000 higher than 1,198 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI